Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a global health
emergency. To improve the understanding of the systemic component of SARS-CoV-2, we …

Objective: The clinical implications of SARS-CoV-2 RNA viremia in blood (RNAemia) remain
uncertain despite gaining more prognostic implications for coronavirus disease 2019 …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA
(vRNA) is detected in the bloodstream of some patients with coronavirus disease 2019 …

Background This study aimed to clarify how SARS-CoV-2 RNAemia is related to COVID-19
critical condition development and mortality in comparison with other predictive markers and …

Abstract Determinants of Post-Acute Sequelae of COVID-19 are not known. Here we show
that 83.3% of patients with viral RNA in blood (RNAemia) at presentation were symptomatic …

Background Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
RNA in blood, also known as RNAemia, has been reported, but its prognostic implications …

Background Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated
with worse COVID-19 outcome. However, whether specific population can be at higher risk …

Severe/critical COVID-19 is associated with immune dysregulation and plasmatic SARS-
CoV-2 detection (ie RNAemia). We detailed the association of SARS-CoV-2 RNAemia with …

The disease spectrum of coronavirus disease 2019 (COVID‐19) varies from asymptomatic
infection to critical illness and death. Identification of prognostic markers is vital for predicting …

The kinetics of the SARS-CoV-2 viral load in respiratory airways and other tissues is of great
interest to understand the pathogenesis, course, and the management of COVID-19 …